Acura Pharmaceuticals, Inc. - ACUR - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Acura Pharmaceuticals, Inc. - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
ACUR	Nasdaq	8731	http://acurapharm.com	2.37 +0.01
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Acura Pharmaceuticals, Inc. Acura Pharmaceuticals Is Grossly Undervalued And Poised For Rapid Growth - May 17th, 2013 9:04 am 3 Companies That Put the "Tech" in "Biotech" - May 16th, 2013 12:05 pm No Relief in Sight for Pain Investors - May 12th, 2013 1:51 pm Pain Therapeutics, Durect fall on Remoxy review - May 10th, 2013 9:35 am Pain Therapeutics, Durect fall on Remoxy review - May 10th, 2013 9:35 am ACURA PHARMACEUTICALS, INC Financials - May 8th, 2013 11:04 am Acura Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript - May 3rd, 2013 1:10 pm Learn Which Antibody Companies Show Show a Higher Probability of Success; Antibodies Have a Higher Track Record of M&A and More Predictable Toxicology Profile - May 3rd, 2013 10:09 am Acura Pharmaceuticals Announces First Quarter 2013 Financial Results - May 2nd, 2013 2:10 pm ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an - May 2nd, 2013 7:32 am Q1 2013 Acura Pharmaceuticals, Inc. Earnings Release - After Market Close - May 2nd, 2013 5:07 am Why Did Pain Therapeutics Increase Over 25%? - May 1st, 2013 11:15 pm The Fool Looks Ahead - Apr 27th, 2013 5:15 am Acura Pharmaceuticals to Host First Quarter 2013 Financial Results Conference Call on May 3, 2013 - Apr 22nd, 2013 2:55 pm Acura Pharmaceuticals to Host First Quarter 2013 Financial Results Conference Call on May 3, 2013 - Apr 22nd, 2013 2:15 pm Society And The FDA Are Ready For Acura, Are You? - Apr 19th, 2013 5:42 pm The Hidden Winner of the FDA’s Anti-Generic Decision - Apr 18th, 2013 7:14 pm 4 Healthcare Stock Stories for Thursday Investment Wellness - Apr 18th, 2013 3:07 pm Whoa! What Just Happened to My Stock? - Apr 18th, 2013 2:50 pm 5 Stocks Under $10 Set to Soar - Apr 18th, 2013 11:11 am View All Current Headlines >>